Clinical Trials Directory

Trials / Completed

CompletedNCT02469259

The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD

The Effects of Oxytocin on Social Ability, Alcohol Approach Bias, and Startle Hyperreactivity in Veterans With Alcohol Use Disorder and Post Traumatic Stress Disorder

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study will investigate the effects of oxytocin on alcohol-related behaviors, social abilities, and physiological startle responses in healthy individuals and patients with posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) using a randomized, placebo-controlled, dose-tiered, between-subject study design. Specifically, the investigators will determine if intranasal administration of a single dose of the pro-social neuropeptide oxytocin decreases alcohol-related approach bias and cravings, enhances social abilities, and decreases physiological hyperactivity. The investigators will also determine the optimal dose to achieve these effects and will explore psychosocial predictors of responses to oxytocin. The proposed work has the potential to yield a novel pharmacological treatment for AUD and PTSD, both leading causes of disability in the US Military for which currently available treatments are inadequate.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin
OTHERPlacebo

Timeline

Start date
2016-02-01
Primary completion
2018-02-28
Completion
2018-02-28
First posted
2015-06-11
Last updated
2019-05-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02469259. Inclusion in this directory is not an endorsement.